154 related articles for article (PubMed ID: 31969757)
1. PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS.
Mihić J; Rotim K; Vučić M; Hude Dragičević I; Borić M; Lugović-Mihić L
Acta Clin Croat; 2019 Sep; 58(3):455-462. PubMed ID: 31969757
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
3. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
5. CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.
Liu WH; Lin JC; Chou YC; Li MH; Tsai JT
Cancer Med; 2020 Jan; 9(1):350-360. PubMed ID: 31746135
[TBL] [Abstract][Full Text] [Related]
6. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
7. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
Behrem S; Zarkovic K; Eskinja N; Jonjic N
Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
[TBL] [Abstract][Full Text] [Related]
8. Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study.
Ariza A; López D; Mate JL; Isamat M; Musulén E; Pujol M; Ley A; Navas-Palacios JJ
Hum Pathol; 1995 Oct; 26(10):1144-7. PubMed ID: 7557949
[TBL] [Abstract][Full Text] [Related]
9. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
11. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
[TBL] [Abstract][Full Text] [Related]
12. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A
Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155
[TBL] [Abstract][Full Text] [Related]
13. Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma.
Sica G; Lama G; Anile C; Geloso MC; La Torre G; De Bonis P; Maira G; Lauriola L; Jhanwar-Uniyal M; Mangiola A
Int J Oncol; 2011 Jan; 38(1):41-9. PubMed ID: 21109924
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
15. CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma.
Nishikawa M; Inoue A; Ohnishi T; Yano H; Kanemura Y; Kohno S; Ohue S; Ozaki S; Matsumoto S; Suehiro S; Nakamura Y; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T
Cancer Med; 2021 Mar; 10(6):2013-2025. PubMed ID: 33543833
[TBL] [Abstract][Full Text] [Related]
16. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
17. Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo.
Shankar A; Kumar S; Iskander AS; Varma NR; Janic B; deCarvalho A; Mikkelsen T; Frank JA; Ali MM; Knight RA; Brown S; Arbab AS
Chin J Cancer; 2014 Mar; 33(3):148-58. PubMed ID: 24016393
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma CD105
Li J; Ek F; Olsson R; Belting M; Bengzon J
Acta Neuropathol Commun; 2022 Aug; 10(1):126. PubMed ID: 36038950
[TBL] [Abstract][Full Text] [Related]
19. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.
Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of stem cell markers CD44 and nestin in glioblastomas: Evaluation of their prognostic significance.
Guadagno E; Borrelli G; Califano M; Calì G; Solari D; Del Basso De Caro M
Pathol Res Pract; 2016 Sep; 212(9):825-32. PubMed ID: 27450656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
